Weight loss drug could reduce heart attack risk by 20%, study finds The GuardianWhat the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and heart protection CNNObesity drug cuts risk of heart attack or stroke regardless of weight lost, study finds Sky NewsWegovy weight loss sustained for four years in trial, Novo Nordisk says ReutersWeight loss jab could reduce heart attack risk, study finds BBC.com